Liquid biopsy for lung cancer early detection

Molecularly targeted therapies and immune checkpoint inhibitors have markedly improved the therapeutic management of advanced lung cancer. However, it still remains the leading cause of cancer-related mortality worldwide, with disease stage at diagnosis representing the main prognostic factor. Detec...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Thorac Dis
Autors principals: Santarpia, Mariacarmela, Liguori, Alessia, D’Aveni, Alessandro, Karachaliou, Niki, Gonzalez-Cao, Maria, Daffinà, Maria Grazia, Lazzari, Chiara, Altavilla, Giuseppe, Rosell, Rafael
Format: Artigo
Idioma:Inglês
Publicat: AME Publishing Company 2018
Matèries:
Review Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5945693/
https://ncbi.nlm.nih.gov/pubmed/29780635
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2018.03.81
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars